Status ViroPharma has completed Phase 2 - enabling toxicology studies with VP 20629, and has initiated Phase 1b testing in patients with Friedreich's ataxia.
- The Complete Phase Ib Trial Design Design - An Approach for Getting to Phase II Faster
... Known as “the complete phase 1b,” the design streamlines phase 1 by testing various drug combinations in one trial with multiple arms running in parallel. This structure creates rapid accrual rates, substantial economies of scale and significant time savings for sponsors versus the traditional sequential approach. It also garners enthusiasm from investigators and patients, who ultimately gain greater potential for improved therapeutic benefits and care. ...